Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

Carbapenem-Based Antibiotics Market: What is the Projected CAGR for 2024-2033?

The market size of carbapenem-based antibiotics has experienced robust growth in the past few years. It is predicted to escalate from $4.43 billion in 2023 to $4.66 billion in 2024, with a compound annual growth rate (CAGR) of 5.1%. The significant growth in the prior years can be credited to factors such as epidemics and pandemics, an increase in chronic diseases, expansion of healthcare infrastructure, quick urbanization, natural calamities, and health crises.

The market size of carbapenem-based antibiotics is projected to witness a significant increase in the coming years, reaching $5.71 billion by 2028 with a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be associated with the rising occurrences of hospital-based infections, the emergence of multi-drug resistant strains, an increasing elderly population, a surge in surgical procedures, the spread of infectious diseases, and shifting demographics. Key trends for the forecast period incorporate resilience and security of the supply chain, the progress of alternative treatments, a transition towards outpatient settings, a growing consciousness regarding antimicrobial stewardship, and the adoption of precision medicine tactics.

Claim Your Free Sample of the Global Carbapenem-Based Antibiotics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12035&type=smp

What Are the Primary Drivers Supporting the Growth of the carbapenem-based antibiotics Market?

The carbapenem-based antibiotics market is projected to expand, driven by the escalating prevalence of bacterial infections. Infections induced by bacteria – microscopic organisms capable of infiltrating the body, triggering a multitude of diseases and symptoms – are known as bacterial infections. Carbapenem-based antibiotics are used to tackle serious or multi-drug resistant bacterial infections, inclusive of those instigated by gram-positive and gram-negative bacteria. For example, a report by the UK Health Security Agency (UKHSA), an executive arm of the Department of Health and Social Care in England, revealed in November 2022 that the projected total number of antibiotic-resistant serious infections escalated by 2.2% in 2021. As such, the surge in bacterial infections propels the advancement of the carbapenem-based antibiotics market.

What Are the Core Segments of the Carbapenem-Based Antibiotics Market?

1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types

2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Trends Are Paving the Way for Change in the Carbapenem-Based Antibiotics Market?

Product innovation is emerging as a significant trend in the carbapenem-based antibiotics market. To maintain their market standing, leading corporations are focusing on new product developments. BDR Pharmaceuticals International Pvt. Ltd, an Indian pharmaceutical company, for example, launched a product known as biapenem in September 2021. Biapenem is used for treating individuals with lower respiratory infections, complicated urinary tract infections, or intra-abdominal infections. It has shown clinical and bacteriological effectiveness, similar to imipenem/cilastatin, for these types of diseases.

Order Now for Fast Delivery of Your Carbapenem-Based Antibiotics Market Report!

https://www.thebusinessresearchcompany.com/report/carbapenem-based-antibiotics-global-market-report

Which Regions Are Leading the Charge in Carbapenem-Based Antibiotics Market Development?

North America was the largest region in the Carbapenem-Based Antibiotics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the carbapenem-based antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Carbapenem-Based Antibiotics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the carbapenem-based antibiotics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Carbapenem-Based Antibiotics Market Include

1. Carbapenem-Based Antibiotics Market Executive Summary

2. Carbapenem-Based Antibiotics Market Segments

3. Carbapenem-Based Antibiotics Market Size And Template Market Growth Rate

4. Key Carbapenem-Based Antibiotics Market Trends

5. Major Carbapenem-Based Antibiotics Market Drivers

……

25. Key Mergers And Acquisitions In The Carbapenem-Based Antibiotics Market

26. Top Carbapenem-Based Antibiotics Companies

27. Carbapenem-Based Antibiotics Market Opportunities And Strategies

28. Carbapenem-Based Antibiotics Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: